83_FR_3186 83 FR 3171 - Meeting of the Tick-Borne Disease Working Group

83 FR 3171 - Meeting of the Tick-Borne Disease Working Group

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 83, Issue 15 (January 23, 2018)

Page Range3171-3171
FR Document2018-01149

The Department of Health and Human Services (HHS) announces the third meeting of the Tick-Borne Disease Working Group (Working Group) on February 12, 2018, from 12:00 p.m. to 4:00 p.m., Eastern Time. For this third meeting, the Working Group will focus on mapping out the work of the six Subcommittee Meeting Working Groups that were established on December 12, 2017. These subcommittees were established to assist the Working Group with the development of the report to Congress and the HHS Secretary as required by the 21st Century Cures Act. The subcommittees are: 1. Disease Vectors, Surveillance and Prevention (includes epidemiology of tick-borne diseases); 2. Pathogenesis, Transmission, and Treatment; 3. Testing and Diagnostics (including laboratory-based diagnoses and clinical-diagnoses); 4. Access to Care Services and Support to Patients; 5. Vaccine and Therapeutics; and 6. Other Tick-Borne Diseases and Co-infections.

Federal Register, Volume 83 Issue 15 (Tuesday, January 23, 2018) 
[Federal Register Volume 83, Number 15 (Tuesday, January 23, 2018)]
[Notices]
[Page 3171]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-01149]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Tick-Borne Disease Working Group

AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the 
Assistant Secretary for Health, Office of the Secretary, Department of 
Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) announces 
the third meeting of the Tick-Borne Disease Working Group (Working 
Group) on February 12, 2018, from 12:00 p.m. to 4:00 p.m., Eastern 
Time. For this third meeting, the Working Group will focus on mapping 
out the work of the six Subcommittee Meeting Working Groups that were 
established on December 12, 2017. These subcommittees were established 
to assist the Working Group with the development of the report to 
Congress and the HHS Secretary as required by the 21st Century Cures 
Act. The subcommittees are:
    1. Disease Vectors, Surveillance and Prevention (includes 
epidemiology of tick-borne diseases);
    2. Pathogenesis, Transmission, and Treatment;
    3. Testing and Diagnostics (including laboratory-based diagnoses 
and clinical-diagnoses);
    4. Access to Care Services and Support to Patients;
    5. Vaccine and Therapeutics; and
    6. Other Tick-Borne Diseases and Co-infections.

DATES: February 12, 2018, from 12:00 p.m. to 4:00 p.m., Eastern Time.

ADDRESSES: This will be a virtual meeting that is held via webcast. 
Members of the public may attend the meeting via webcast and 
instructions for attending this virtual meeting will be posted one week 
prior to the meeting at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/index.html.

FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and 
Infectious Disease Policy, Office of the Assistant Secretary for 
Health, Department of Health and Human Services; via email at 
[email protected] or by phone at 202-795-7697.

SUPPLEMENTARY INFORMATION: At this meeting, the Working Group will also 
hear about one or more examples of other efforts that have been 
successfully undertaken to define a national or statewide approach to 
preventing, monitoring, diagnosing, and treating people with tick-borne 
diseases. In addition, federal resources, within and outside of HHS, 
that may be of use to the subcommittees as they do their work, such as 
the Department of Health and Human Services Internal Working Group on 
Lyme and Other Tick-Borne Diseases, will be presented.
    The Working Group invites public comment on issues related to the 
Working Group's charge. Comments may be provided over the phone during 
the meeting or in writing. Persons who wish to provide comments by 
phone should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html before submitting a 
request via email at [email protected] on or before February 7, 
2018. Phone comments will be limited to three minutes each to 
accommodate as many speakers as possible. A total of 30 minutes will be 
allocated to public comments. If more requests are received than can be 
accommodated, speakers will be randomly selected. The nature of the 
comments will not be considered in making this selection. Public 
comments may also be provided in writing. Individuals who would like to 
provide written comment should review directions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/index.html before sending their comments to [email protected] on 
or before February 7, 2018.
    Background and Authority: The Tick-Borne Disease Working Group was 
established on August 10, 2017, in accordance with section 2062 of the 
21st Century Cures Act, and the Federal Advisory Committee Act, 5 
U.S.C. App., as amended, to provide expertise and review all HHS 
efforts related to tick-borne diseases to help ensure interagency 
coordination and minimize overlap, examine research priorities, and 
identify and address unmet needs. In addition, the Working Group will 
report to the Secretary and Congress on their findings and any 
recommendations for the federal response to tick-borne disease 
prevention, treatment and research, and addressing gaps in those areas.

    Dated: January 17, 2018.
James Berger,
Alternate Designated Federal Officer, Office of HIV/AIDS and Infectious 
Disease Policy, Tick-Borne Disease Working Group.
[FR Doc. 2018-01149 Filed 1-22-18; 8:45 am]
 BILLING CODE 4150-28-P

Federal Register / Vol. 83, No. 15 / Tuesday, January 23, 2018 / Notices 3171 TABLE 3—ESTIMATED ANNUAL THIRD-PARTY DISCLOSURE BURDEN 1—Continued Number of Total Average Number of 21 CFR section responses per annual burden per Total hours respondents respondent responses response 610.47(a)(3) .................................................................. 1,734 11.7630 20,397 .17 (10 min.) ......... 3,467 610.47(b)(3) .................................................................. 4,961 0.4132 2,050 1 ............................ 2,050 630.40(a) 3 .................................................................... 578 742.214 429,000 .08 (5 min.) ........... 34,320 630.40(a) 4 .................................................................... 81 50.00 4,050 1.5 ......................... 6,075 630.40(d)(1) .................................................................. 53 11.83 627 1 ............................ 627 Total ...................................................................... ........................ ........................ ........................ ............................... 57,701 1 There are no capital costs or operating and maintenance costs associated with this collection of information. 2 Five percent of establishments that fall under CLIA that transfuse blood and components and FDA-registered blood establishments (0.05 × 4,961 + 2,303 = 363). 3 Notification of donors determined not to be eligible for donation based on failure to satisfy eligibility criteria. 4 Notification of donors deferred based on reactive test results for evidence of infection due to relevant transfusion-transmitted infections. The burden for this information 3. Testing and Diagnostics (including before submitting a request via email at collection has changed since the last laboratory-based diagnoses and clinical- tickbornedisease@hhs.gov on or before OMB approval. Because of a slight diagnoses); February 7, 2018. Phone comments will decrease in the number of blood 4. Access to Care Services and be limited to three minutes each to establishments during the last 3 years, Support to Patients; accommodate as many speakers as FDA has decreased our recordkeeping 5. Vaccine and Therapeutics; and possible. A total of 30 minutes will be and third party disclosure burden 6. Other Tick-Borne Diseases and Co- allocated to public comments. If more estimates. infections. requests are received than can be DATES: February 12, 2018, from 12:00 Dated: January 17, 2018. accommodated, speakers will be p.m. to 4:00 p.m., Eastern Time. Leslie Kux, randomly selected. The nature of the ADDRESSES: This will be a virtual Associate Commissioner for Policy. comments will not be considered in meeting that is held via webcast. [FR Doc. 2018–01123 Filed 1–22–18; 8:45 am] making this selection. Public comments Members of the public may attend the BILLING CODE 4164–01–P meeting via webcast and instructions for may also be provided in writing. attending this virtual meeting will be Individuals who would like to provide posted one week prior to the meeting at: written comment should review DEPARTMENT OF HEALTH AND https://www.hhs.gov/ash/advisory- directions at https://www.hhs.gov/ash/ HUMAN SERVICES committees/tickbornedisease/ advisory-committees/tickbornedisease/ index.html. meetings/index.html before sending Meeting of the Tick-Borne Disease their comments to tickbornedisease@ Working Group FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and hhs.gov on or before February 7, 2018. AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the Background and Authority: The Tick- Infectious Disease Policy, Office of the Assistant Secretary for Health, Borne Disease Working Group was Assistant Secretary for Health, Office of Department of Health and Human established on August 10, 2017, in the Secretary, Department of Health and Services; via email at tickbornedisease@ accordance with section 2062 of the 21st Human Services. hhs.gov or by phone at 202–795–7697. Century Cures Act, and the Federal SUPPLEMENTARY INFORMATION: At this Advisory Committee Act, 5 U.S.C. App., ACTION: Notice. meeting, the Working Group will also as amended, to provide expertise and SUMMARY: The Department of Health and hear about one or more examples of review all HHS efforts related to tick- Human Services (HHS) announces the other efforts that have been successfully borne diseases to help ensure third meeting of the Tick-Borne Disease undertaken to define a national or interagency coordination and minimize Working Group (Working Group) on statewide approach to preventing, overlap, examine research priorities, February 12, 2018, from 12:00 p.m. to monitoring, diagnosing, and treating and identify and address unmet needs. 4:00 p.m., Eastern Time. For this third people with tick-borne diseases. In In addition, the Working Group will meeting, the Working Group will focus addition, federal resources, within and report to the Secretary and Congress on on mapping out the work of the six outside of HHS, that may be of use to their findings and any recommendations Subcommittee Meeting Working Groups the subcommittees as they do their for the federal response to tick-borne that were established on December 12, work, such as the Department of Health disease prevention, treatment and 2017. These subcommittees were and Human Services Internal Working Group on Lyme and Other Tick-Borne research, and addressing gaps in those established to assist the Working Group areas. with the development of the report to Diseases, will be presented. The Working Group invites public Dated: January 17, 2018. Congress and the HHS Secretary as comment on issues related to the sradovich on DSK3GMQ082PROD with NOTICES required by the 21st Century Cures Act. James Berger, Working Group’s charge. Comments Alternate Designated Federal Officer, Office The subcommittees are: may be provided over the phone during of HIV/AIDS and Infectious Disease Policy, 1. Disease Vectors, Surveillance and the meeting or in writing. Persons who Tick-Borne Disease Working Group. Prevention (includes epidemiology of wish to provide comments by phone tick-borne diseases); [FR Doc. 2018–01149 Filed 1–22–18; 8:45 am] should review directions at https:// BILLING CODE 4150–28–P 2. Pathogenesis, Transmission, and www.hhs.gov/ash/advisory-committees/ Treatment; tickbornedisease/meetings/index.html VerDate Sep<11>2014 17:59 Jan 22, 2018 Jkt 244001 PO 00000 Frm 00062 Fmt 4703 Sfmt 9990 E:\FR\FM\23JAN1.SGM 23JAN1


Document Created: 2018-01-23 01:09:03
Document Modified: 2018-01-23 01:09:03
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesFebruary 12, 2018, from 12:00 p.m. to 4:00 p.m., Eastern Time.
ContactJames Berger, Office of HIV/AIDS and Infectious Disease Policy, Office of the Assistant Secretary for Health, Department of Health and Human Services; via email at [email protected] or by phone at 202-795-7697.
FR Citation83 FR 3171 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR